Last refreshed: July 21, 2026 (US ET)
Back to holdings

SHC

Growth

Sotera Health Co

Health Care·Life Sciences Tools & Services·β 1.84

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets.

Close · 3M

+19.56%

SHC · 3M

+19.56%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 1 AI ETF

AIVL0.534%

as of Jul 17

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals12
Win rate58% (7/12)
Avg buy return+2.40%
AIVLnow 0.534% of fund18 signals

AIVL · Weight decrease · 2d

The fund's allocation to Sotera Health (SHC) has seen a gradual, net decrease over the past week, with its weight drifting from 0.5578% to 0.5344%, punctuated by minor intra-period adjustments. This cadence in portfolio adjustment aligns with AIVL's strategy of discerning true value from value traps, particularly as SHC's share price has experienced substantial appreciation, climbing +14.0% in 30 days and nearing its 52-week high at $17.75. Such price performance likely signals to the AI that SHC's valuation metrics, like Price/Earnings or Price/Book, are becoming less attractive within the pre-filtered US value pool, potentially reducing its "AI score" despite stable underlying fundamentals. WisdomTree's AI, tasked with ranking names by fundamental and valuation metrics to identify genuine value, appears to be incrementally paring exposure to SHC as its relative value proposition potentially diminishes within the fund’s ~100 US value stock universe.

weight 0.550% → 0.534% (-0.016 pp)·stock up 10.7% in the 30 days before

Jul 17·entry $17.75·now $17.42

-1.86%
since Jul 17

AIVL · Weight decrease · 2d

SHC's recent price performance, including a +20.8% 30-day return and +55.9% 1-year return, alongside its current $18.15 price sitting at 94% of its $19.35 52-week high, indicates a diminishing "value" profile. WisdomTree's AIVL fund, which prioritizes US value stocks and employs AI to differentiate genuine value from potential traps, would carefully reassess companies exhibiting such rapid appreciation against its valuation metrics. The observed three-day consecutive weight decrease for SHC, moving from 0.5568% on July 10th to 0.5400% on July 14th, aligns with the period where Sotera Health's market price was nearing its annual peak. The AI's evaluation, factoring in fundamentals alongside metrics like P/E, P/B, and FCF yield, likely identified SHC as becoming less compelling within AIVL's value-factor pool as its price approached the upper end of its historical range.

weight 0.557% → 0.540% (-0.017 pp)·stock up 8.4% in the 30 days before

Jul 14·entry $17.77·now $17.42

-1.97%
since Jul 14

AIVL · Accumulation · 5d

AIVL’s portfolio adjustments for SHC exhibit a clear pattern of gradual accumulation across late June and early July, with holdings rising from 0.5235% to 0.5520%, punctuated by minor recalibrations before resuming an upward trend. This measured cadence, rather than a single large purchase, aligns with WisdomTree’s AI-driven strategy, which periodically scores fundamental and valuation metrics within its pre-filtered US value universe. Despite SHC's significant 1-year return of +56.8% and its current position near 90% of its 52-week high, the sustained accumulation suggests the AI’s intricate analysis of margins, return on capital, and free cash flow yield continues to identify Sotera Health as genuine value, distinguishing it from potential value traps even at an elevated price level. The brief temporary reduction in weighting observed suggests the AI’s ongoing re-evaluation process, confirming the stock's eligibility within its value parameters before increasing exposure further.

weight 0.523% → 0.544% (+0.020 pp)·stock up 15.7% in the 30 days before

Jul 7·entry $18.02·now $17.42Fresh

-3.33%
since Jul 7

AIVL · Accumulation · 5d

WisdomTree's AIVL fund employs AI to identify genuine value opportunities among approximately 100 US value stocks, assessing fundamentals like margins and return on capital, alongside valuation metrics such as P/E and FCF yield. The observed gradual accumulation of SHC, a healthcare company, in late June and early July reflects the AI's function of distinguishing sustainable value from value traps within its pre-filtered universe. This increase occurred as SHC's price approached its 52-week high of $19.35, indicating the AI's models continued to favor the stock's underlying quality and valuation characteristics even after a significant run-up, leading to its higher weighting ahead of a periodic portfolio rebalance.

weight 0.499% → 0.538% (+0.039 pp)·stock up 17.0% in the 30 days before

Jul 6·entry $17.86·now $17.42Fresh

-2.46%
since Jul 6

AIVL · Accumulation · 6d

SHC's current price of $17.93, nearing its 52-week high of $19.35, follows a substantial 1-year return of +57.4% and a 30-day gain of +15.3%. This indicates that despite recent price appreciation, the AI managing WisdomTree's AIVL fund found SHC's underlying fundamentals (margins, return on capital, debt) and valuation metrics (P/E, P/B, FCF yield) within the Health Care sector to align with its criteria for genuine value, rather than a value trap. The gradual accumulation, with AIVL increasing its SHC weighting from 0.4904% on June 22nd to 0.5520% by July 1st, 2026, occurred as the stock continued its upward trajectory. This pattern suggests AIVL's AI likely reaffirmed SHC's favorable fundamental and valuation characteristics, allowing for a continued position increase even as the stock traded at a higher relative price.

weight 0.490% → 0.550% (+0.060 pp)·stock up 19.4% in the 30 days before

Jul 2·entry $17.93·now $17.42Fresh

-2.84%
since Jul 2

AIVL · Accumulation · 6d

Sotera Health Co (SHC) saw a 1-year return of +62.2% and a recent 30-day surge of +16.5% to $17.75, prompting AIVL's AI to evaluate its adherence to value characteristics like strong margins or return on capital. Even as the stock neared 92% of its 52-week high, AIVL's AI likely distinguished SHC as a genuine value opportunity rather than a value trap, scoring favorably on underlying fundamentals and valuation metrics such as P/E, P/B, or FCF yield. Beginning June 23rd, 2026, coinciding with the accelerated price appreciation, the fund initiated a gradual accumulation, increasing its SHC weight from 0.49% to 0.55% by July 1st. This methodical increase reflects the AI's periodic rebalancing mechanism identifying continued strength in SHC's financials that justified its higher weighting within the US value-factor pool, even during a period of short-term growth.

weight 0.496% → 0.552% (+0.056 pp)·stock up 14.2% in the 30 days before

Jul 1·entry $17.75·now $17.42Fresh

-1.86%
since Jul 1

AIVL · Accumulation · 5d

The observed gradual accumulation of SHC within AIVL, with its weighting increasing from 0.5008% to 0.5478% over two weeks in late June, characterizes a phased adjustment rather than an abrupt portfolio shift. This measured cadence is consistent with AIVL's periodic rebalancing methodology, which does not execute daily changes. SHC, a Health Care company currently trading at $17.75 and near 92% of its 52-week high after a 15.6% 30-day return and 62.1% 1-year return, presents a scenario where superficial price metrics might suggest limited value. However, AIVL's AI, specifically designed to use fundamentals and valuation metrics to distinguish genuine value from value traps within its pre-filtered US value universe, appears to have identified sufficient underlying quality in Sotera Health Co to warrant this sustained, incremental increase in allocation. This specific move indicates the AI's discernment beyond simple price momentum within a stock that has seen considerable appreciation.

weight 0.501% → 0.548% (+0.047 pp)·stock up 13.5% in the 30 days before

Jun 30·entry $17.75·now $17.42Fresh

-1.86%
since Jun 30

AIVL · Weight increase · 4d

Sotera Health’s consecutive daily weight increases in AIVL, moving from 0.4989% to 0.5377% over several days, signals a growing conviction in the stock. This sustained allocation comes as SHC trades at $17.52, having posted a 14.7% return in 30 days and now sitting at 91% of its 52-week high. WisdomTree's AI, specifically designed to distinguish genuine value from value traps within an already value-tilted pool, appears to view SHC as meriting this increased position. The AI's continuous evaluation of fundamentals such as margins, return on capital, and debt, alongside valuation metrics like P/E and FCF yield, suggests that the recent price appreciation is fundamentally sound rather than speculative, leading to a higher target weight.

weight 0.490% → 0.538% (+0.047 pp)·stock up 11.8% in the 30 days before

Jun 26·entry $17.38·now $17.42Fresh

+0.23%
since Jun 26

AIVL · Weight increase · 3d

Sotera Health Co's 30-day return of +12.2% and a 1-year return of +52.1% reflect its recent market performance, indicating a re-assessment of its underlying value characteristics consistent with AIVL's strategy to identify genuine value beyond mere low price-to-book within its pre-filtered US value-factor universe. The AI-managed fund consecutively raised SHC's weight from 0.4989% to 0.5279% between June 23 and June 25, during which the stock experienced part of its recent price momentum. Even with the current price of $17.38 placing it near 90% of its 52-week high, AIVL's algorithm evidently determined that SHC’s fundamentals, such as margins or return on capital, alongside its valuation metrics, continue to present a compelling case for increased allocation within its ~100 US value stock portfolio.

weight 0.490% → 0.528% (+0.037 pp)·stock up 7.1% in the 30 days before

Jun 25·entry $17.10·now $17.42Fresh

+1.87%
since Jun 25

AIVL · Weight increase · 2d

The weight of Sotera Health Co in AIVL underwent a distinct pattern, declining over several days to 0.4904% before a rapid, two-day increase on June 23rd and 24th, reaching 0.5235% of the portfolio. This quick reversal, where the fund boosted its allocation by approximately 6.7% from its recent low, suggests AIVL's AI-driven strategy re-evaluated SHC's position within its value universe. Operating within its specific value-factor mandate, the AI likely discerned an improvement in SHC's underlying fundamental metrics—such as margins, return on capital, or free cash flow yield—that re-aligned its valuation appeal. This shift allowed for a renewed allocation to the Health Care company, even as the stock trades at $16.69, which is 86% of its 52-week high, indicating a conviction in its value despite recent price appreciation. Given AIVL’s objective to distinguish genuine value from value traps, this specific move points to the AI algorithm identifying compelling attributes in Sotera Health Co's financial health, justifying an increased weighting following its reassessment.

weight 0.490% → 0.523% (+0.033 pp)·stock up 6.6% in the 30 days before

Jun 24·entry $16.69·now $17.42Drifting

+4.37%
since Jun 24

AIVL · Weight decrease · 5d

SHC, currently priced at $15.74, stands at 81% of its 52-week high, reflecting a 27.3% gain over one year despite a recent -9.4% return over 90 days. This pattern of a strong annual performance followed by a correctional dip directly engages AIVL's strategy of discerning true value from value traps within its pre-filtered US value universe. The ETF’s AI component, which scores names based on fundamentals like margins and return on capital, alongside valuation metrics, appears to have re-evaluated SHC. A consecutive reduction in SHC’s weight from 0.5212% on June 11th to 0.4904% by June 22nd indicates the AI's continuous analysis suggested the Health Care sector stock no longer aligned as strongly with its value criteria at this price level, potentially identifying a shift towards a less favorable risk/reward profile.

weight 0.528% → 0.490% (-0.037 pp)·stock up 1.2% in the 30 days before

Jun 22·entry $15.74·now $17.42

+10.67%
since Jun 22

AIVL · Weight decrease · 4d

Sotera Health Co's current price of $15.82, while experiencing a -9.4% 90-day return, still resides at 82% of its 52-week high. This price context, coupled with AIVL's method of evaluating US value-factor stocks using fundamentals like margins, return on capital, debt, and valuation metrics such as P/E, P/B, and FCF yield, informed the AI's recent actions. AIVL recorded a consecutive weight decrease for SHC, moving from 0.5212% on June 11th to 0.4964% by June 18th, indicating the fund's AI likely identified a diminished fundamental appeal or less attractive valuation relative to its ~100-stock value universe. The AI, specifically designed to distinguish genuine value from value traps, appears to have determined SHC's recent price movement did not sufficiently enhance its value profile or that its underlying financial health signals a concern, prompting reduced exposure in the portfolio.

weight 0.528% → 0.496% (-0.031 pp)·stock up 3.9% in the 30 days before

Jun 18·entry $15.82·now $17.42

+10.11%
since Jun 18

AIVL · Weight decrease · 3d

The WisdomTree AIVL fund, which uses AI to distinguish genuine value from value traps within its US value-factor pool, initiated a consecutive weight decrease in Sotera Health Co, commencing after June 10th and continuing to June 16th, reducing its allocation from 0.5212% to 0.5008%. This adjustment occurred as SHC's 90-day return stood at -11.2%, with the stock's current price of $15.46 remaining at 80% of its 52-week high despite recent declines. The AI's scoring mechanism, which evaluates fundamentals such as margins, return on capital, and debt, along with valuation metrics including P/E, P/B, and FCF yield, likely detected a relative deterioration or a lack of sufficient strengthening in these areas. AIVL's AI, rather than viewing the recent price softness as an enhanced value opportunity, appears to have reassessed SHC's long-term genuine value proposition compared to other stocks in its approximately 100-stock value universe, leading to the measured reduction in its position.

weight 0.528% → 0.501% (-0.027 pp)·stock up 5.0% in the 30 days before

Jun 16·entry $16.04·now $17.42

+8.60%
since Jun 16

AIVL · Weight decrease · 2d

Sotera Health Co. (SHC) currently trades at $16.23, positioning it at 84% of its $19.35 52-week high, following a 5.5% return in the last 30 days and a 32.2% gain over the past year. This recent upward price movement likely influenced AIVL's AI engine to re-evaluate SHC within its pre-filtered US value-factor pool. As a WisdomTree fund specifically tasked with distinguishing genuine value from value traps, AIVL’s algorithm assesses fundamental data, including margins and return on capital, alongside valuation metrics such as P/E and FCF yield. The subsequent consecutive weight decreases for SHC, from 0.5276% on June 10 to 0.5212% on June 11, and further to 0.5097% on June 12, indicate the AI's scoring system determined the healthcare company's relative attractiveness had diminished, potentially due to its higher market price impacting its valuation against other value candidates.

weight 0.528% → 0.510% (-0.018 pp)·stock up 4.6% in the 30 days before

Jun 12·entry $16.19·now $17.42

+7.60%
since Jun 12

AIVL · Accumulation · 5d

Sotera Health Co. currently trades at $16.39, sitting at 85% of its 52-week high after experiencing a 90-day decline of 9.2% despite a 33.9% gain over the past year. This specific pullback within a generally ascending longer-term trend likely presented a compelling entry point for WisdomTree AIVL’s initial value-factor screen. The AI within AIVL, tasked with distinguishing genuine value from value traps in its US value pool, subsequently initiated a gradual accumulation of SHC shares. This systematic increase in weight, specifically from 0.3237% on May 15 to 0.5212% by June 11, indicates the AI's models are detecting strengthening signals in SHC's underlying fundamentals, such as margins, return on capital, or debt levels, combined with attractive valuation metrics like P/E, P/B, or FCF yield. The AI's consistent buying activity during this period suggests it identified a favorable risk-reward profile for Sotera Health within the healthcare sector, aligning with AIVL's precise mandate to leverage artificial intelligence for identifying true value opportunities.

weight 0.324% → 0.521% (+0.198 pp)·stock up 4.9% in the 30 days before

Jun 11·entry $16.39·now $17.42Drifting

+6.28%
since Jun 11

AIVL · Accumulation · 5d

The weight change in Sotera Health Co. (SHC) within AIVL displays a distinct pattern: a subtle initial increase in mid-May, followed by a substantial jump from 0.3237% to 0.4999% at the start of June, then continued incremental accumulation to 0.5276% over the following week. This mixed cadence aligns with AIVL's strategy of using AI to score names within a pre-filtered US value pool. Operating with periodic rebalances rather than daily shifts, AIVL's AI likely identified SHC, a health care company, as a genuine value proposition after its 90-day price decline of 11.1%. At its current price of $16.27, representing 84% of its 52-week high, the AI's fundamental analysis encompassing margins, return on capital, and debt, alongside valuation metrics like P/E and FCF yield, probably signaled that SHC was not a value trap. The substantial initial allocation followed by smaller, consistent additions suggests the AI developed conviction around the stock as it recovered 5.3% over 30 days, demonstrating how WisdomTree’s AI distinguishes genuine value at a point when recent performance created a potential entry point within its value-tilted universe.

weight 0.323% → 0.528% (+0.205 pp)·stock up 5.4% in the 30 days before

Jun 10·entry $16.27·now $17.42Drifting

+7.07%
since Jun 10

AIVL · Weight increase · 3d

AIVL's AI, designed to distinguish genuine value from value traps within its approximately 100 US value stock universe, appears to have developed increased conviction in SHC. The fund's methodology, which evaluates companies using fundamental metrics like margins and return on capital alongside valuation ratios such as P/E and FCF yield, likely found SHC's profile increasingly attractive. Following a significant weight increase around June 1st, the AI continued to sequentially boost SHC's allocation through June 8th. This sustained accumulation suggests the AI perceives the current $16.53 price, sitting at 85% of its 52-week high, as an appealing entry point, especially after its recent 90-day return of -8.8% potentially improved its valuation scores.

weight 0.489% → 0.513% (+0.024 pp)·stock up 1.2% in the 30 days before

Jun 8·entry $15.86·now $17.42Drifting

+9.84%
since Jun 8

AIVL · Weight increase · 2d

weight 0.489% → 0.507% (+0.018 pp)·stock down 1.1% in the 30 days before

Jun 5·entry $15.62·now $17.42Chased

+11.52%
since Jun 5

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.